awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37461942-42AE6D0F-519D-4604-BECD-DFD151167BC5
Q37461942-42AE6D0F-519D-4604-BECD-DFD151167BC5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37461942-42AE6D0F-519D-4604-BECD-DFD151167BC5
Long-term efficacy and safety of bosutinib in patients with advanced leukemia following resistance/intolerance to imatinib and other tyrosine kinase inhibitors.
P2860
Q37461942-42AE6D0F-519D-4604-BECD-DFD151167BC5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37461942-42AE6D0F-519D-4604-BECD-DFD151167BC5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
210ae297f7a7514dfbbaf97a2aae5952e3f8c2fd
P2860
Activity of bosutinib, dasatinib, and nilotinib against 18 imatinib-resistant BCR/ABL mutants.